SOLO-1: Frontline Olaparib Maintenance Therapy in Ovarian Cancer
4 ভিউ
administrator
07/08/23
Experts review the SOLO-1 trial and olaparib’s role as maintenance therapy following the frontline management of ovarian cancer.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
আরো দেখুন
ফেসবুক মন্তব্য
কোন মন্তব্য পাওয়া যায়নি